Government of Jordan Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2016
NCT03526276
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ministry of Health Jordan | Regional Center for Disease Control and Prevention, Jordan | Scientific Research Fund, Ministry of Higher Education and Research, Jordan | The Jordanian Ministry of Health

Active Ingredients

Drugs in Phase 3 Trials (1)

hydroxychloroquine (plaquenil) (2 trials)

Drugs in Other Trials (2)

casein phosphopeptide amorphous calcium phosphate (1 trial)

sodium fluoride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3